Fesilty is supplied as a lyophilized powder for reconstitution in a single-dose vial containing approximately 1g of human fibrinogen.
Andexxa is a recombinant modified human factor Xa protein that received accelerated approval in 2018 for reversal of anticoagulation with rivaroxaban or apixaban due to life-threatening or ...
Bisphosphonates may reduce pain intensity in short term, but may result in little to no difference in immediate and medium term.
HealthDay News — The proportion of newborns not receiving intramuscular vitamin K increased from 2017 to 2024, according to a research letter published online December 8 in the Journal of the American ...
HealthDay News — The US Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients to a possible risk for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results